Anti-NNAT monoclonal antibody

Pre-made anti-NNAT monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to NNAT/NNAT products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1273-Ab-1/ GM-Tg-hg-IP1273-Ab-2Anti-Human NNAT monoclonal antibodyHuman
GM-Tg-rg-IP1273-Ab-1/ GM-Tg-rg-IP1273-Ab-2Anti-Rat NNAT monoclonal antibodyRat
GM-Tg-mg-IP1273-Ab-1/ GM-Tg-mg-IP1273-Ab-2Anti-Mouse NNAT monoclonal antibodyMouse
GM-Tg-cynog-IP1273-Ab-1/ GM-Tg-cynog-IP1273-Ab-2Anti-Cynomolgus/ Rhesus macaque NNAT monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1273-Ab-1/ GM-Tg-felg-IP1273-Ab-2Anti-Feline NNAT monoclonal antibodyFeline
GM-Tg-cang-IP1273-Ab-1/ GM-Tg-cang-IP1273-Ab-2Anti-Canine NNAT monoclonal antibodyCanine
GM-Tg-bovg-IP1273-Ab-1/ GM-Tg-bovg-IP1273-Ab-2Anti-Bovine NNAT monoclonal antibodyBovine
GM-Tg-equg-IP1273-Ab-1/ GM-Tg-equg-IP1273-Ab-2Anti-Equine NNAT monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1273-Ab-1/ GM-Tg-hg-IP1273-Ab-2; GM-Tg-rg-IP1273-Ab-1/ GM-Tg-rg-IP1273-Ab-2;
GM-Tg-mg-IP1273-Ab-1/ GM-Tg-mg-IP1273-Ab-2; GM-Tg-cynog-IP1273-Ab-1/ GM-Tg-cynog-IP1273-Ab-2;
GM-Tg-felg-IP1273-Ab-1/ GM-Tg-felg-IP1273-Ab-2; GM-Tg-cang-IP1273-Ab-1/ GM-Tg-cang-IP1273-Ab-2;
GM-Tg-bovg-IP1273-Ab-1/ GM-Tg-bovg-IP1273-Ab-2; GM-Tg-equg-IP1273-Ab-1/ GM-Tg-equg-IP1273-Ab-2
Products NameAnti-NNAT monoclonal antibody
Formatmab
Target NameNNAT
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-NNAT monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1273-Ag-1Recombinant multi-species NNAT/ Peg5 protein


    Target information

    Target IDGM-IP1273
    Target NameNNAT
    Gene ID4826,18111,94270,700562,609195,101099954,353114,100055414
    Gene Symbol and Synonyms5730414I02Rik,NNAT,Peg5
    Uniprot AccessionQ16517,Q62649,Q3ZBS9
    Uniprot Entry NameNNAT_HUMAN,NNAT_RAT,NNAT_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000053438
    Target ClassificationN/A

    The target: NNAT, gene name: NNAT, also named as Peg5. The protein encoded by this gene is a proteolipid that may be involved in the regulation of ion channels during brain development. The encoded protein may also play a role in forming and maintaining the structure of the nervous system. This gene is found within an intron of another gene, bladder cancer associated protein, but on the opposite strand. This gene is imprinted and is expressed only from the paternal allele. [provided by RefSeq, Apr 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.